Act now on flexible drug licensing, UK to tell Europe
This article was originally published in SRA
Executive Summary
The UK prime minister plans to press the case for less “red tape” in the EU when he attends next week's Council meeting. Among other things, David Cameron will call for the introduction of quicker, more flexible drug approval procedures for new medicines and the rapid adoption of the draft EU Clinical Trials Regulation.